$APLS (+22.9% pre) Apellis Pharmaceuticals (APLS) Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of Geographic Atrophy - SI   https://t.co/Y7ch8K3a2m